These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8788040)

  • 1. Receptor-selective retinoids implicate retinoic acid receptor alpha and gamma in the regulation of bmp-2 and bmp-4 in F9 embryonal carcinoma cells.
    Rogers MB
    Cell Growth Differ; 1996 Jan; 7(1):115-22. PubMed ID: 8788040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP4- and RA-induced apoptosis is mediated through the activation of retinoic acid receptor alpha and gamma in P19 embryonal carcinoma cells.
    Glozak MA; Rogers MB
    Exp Cell Res; 1998 Jul; 242(1):165-73. PubMed ID: 9665814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha.
    Kamei Y; Kawada T; Mizukami J; Sugimoto E
    Life Sci; 1994; 55(16):PL307-12. PubMed ID: 7934625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
    Roy B; Taneja R; Chambon P
    Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
    Bjersing JL; Brorsson A; Heby O
    J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
    Clifford JL; Petkovich M; Chambon P; Lotan R
    Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells.
    Gianni M; Zanotta S; Terao M; Garattini S; Garattini E
    Biochem Biophys Res Commun; 1993 Oct; 196(1):252-9. PubMed ID: 8216300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
    Haxsen V; Adam-Stitah S; Ritz E; Wagner J
    Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids differentially regulate the proliferation of colon cancer cell lines.
    Stewart LV; Thomas ML
    Exp Cell Res; 1997 Jun; 233(2):321-9. PubMed ID: 9194494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
    Li Y; Glozak MA; Smith SM; Rogers MB
    Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different response to retinoic acid of two teratocarcinoma cell lines.
    Wan YJ; Wang L; Wu TC
    Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
    Su D; Gudas LJ
    Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the slow induction of apolipoprotein A-I synthesis by retinoids in cynomolgus hepatocytes: involvement of retinoic acid and retinoid X receptors.
    Kaptein A; Neele DM; Twisk J; Hendriks HF; Kooistra T; Princen HM
    J Lipid Res; 1997 Nov; 38(11):2273-80. PubMed ID: 9392425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
    Wan YJ; Cai Y; Magee TR
    Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
    Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
    Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism.
    Boylan JF; Lufkin T; Achkar CC; Taneja R; Chambon P; Gudas LJ
    Mol Cell Biol; 1995 Feb; 15(2):843-51. PubMed ID: 7823950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.